|
|
||||||||
Ann Thorac Surg 1982;34:680-683
© 1982 The Society of Thoracic Surgeons
From the Departments of Surgery and Anesthesiology, The Milton S. Hershey Medical Center, College of Medicine, The Pennsylvania State University, Hershey, PA 17033
Accepted for publication February 19, 1982.
* Address reprint requests to Dr. Parr, Presbyterian–University of Pennsylvania Medical Center, 51 N 39th St, Philadelphia, PA 19104
Hetastarch, a synthetic colloid osmotic plasma volume expander, was employed in a prime for cardiopulmonary bypass in 37 patients undergoing myocardial revascularization. Comparison of laboratory values to those of 42 patients undergoing myocardial revascularization using an albumin-containing prime showed lower postoperative platelet counts (p < 0.02) with hetastarch. There were no differences in chest tube drainage, blood use, plasma hemoglobin, fibrinogen levels, or coagulation times. The hetastarch prime cost $119.50 per patient, whereas the albumin-containing prime cost $321.35 per patient.
This article has been cited by other articles:
![]() |
M. H. Appelman, L. J. M. van Barneveld, J. W. A. Romijn, A. B. A. Vonk, and C. Boer The impact of balanced hydroxylethyl starch cardiopulmonary bypass priming solution on the fibrin part of clot formation: ex vivo rotation thromboelastometry Perfusion, May 1, 2011; 26(3): 175 - 180. [Abstract] [PDF] |
||||
![]() |
A. G. Bailey, P. P. McNaull, E. Jooste, and J. B. Tuchman Perioperative Crystalloid and Colloid Fluid Management in Children: Where Are We and How Did We Get Here? Anesth. Analg., February 1, 2010; 110(2): 375 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Gu and P. W. Boonstra Selection of priming solutions for cardiopulmonary bypass in adults MMCTS, January 1, 2006; 2006(0109): mmcts.2005.001198 - mmcts.2005.001198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shander, T. Rijhwani, D. Moskowitz, and R. Spence Blood and Starch in Cardiac Surgery Chest, June 1, 2004; 125(6): 2369 - 2370. [Full Text] [PDF] |
||||
![]() |
M. E. Barron, M. M. Wilkes, and R. J. Navickis A Systematic Review of the Comparative Safety of Colloids Arch Surg, May 1, 2004; 139(5): 552 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text] |
||||
![]() |
M. M. Wilkes, R. J. Navickis, and W. J. Sibbald Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding Ann. Thorac. Surg., August 1, 2001; 72(2): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L Zarro, D. A Palanzo, and T. G Phillips Albumin in the pump prime: its effect on postoperative weight gain Perfusion, March 1, 2001; 16(2): 129 - 135. [Abstract] [PDF] |
||||
![]() |
D. A Palanzo, D. L Zarro, R. M Montesano, and N. J Manley Albumin in the cardiopulmonary bypass prime: how little is enough? Perfusion, May 1, 1999; 14(3): 167 - 172. [Abstract] [PDF] |
||||
![]() |
I. Tigchelaar, R. C. G. Huet, P. W Boonstra, and W. van Oeveren Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients Perfusion, September 1, 1998; 13(5): 297 - 303. [Abstract] [PDF] |
||||
![]() |
J. T. Cope, D. Banks, M. C. Mauney, T. Lucktong, K. S. Shockey, I. L. Kron, and C. G. Tribble Intraoperative Hetastarch Infusion Impairs Hemostasis After Cardiac Operations Ann. Thorac. Surg., January 1, 1997; 63(1): 78 - 83. [Abstract] [Full Text] |
||||
![]() |
J. M. Yim, L. C. Vermeulen, B. L. Erstad, K. A. Matuszewski, D. A. Burnett, and P. H. Vlasses Albumin and Nonprotein Colloid Solution Use in US Academic Health Centers Arch Intern Med, December 11, 1995; 155(22): 2450 - 2455. [Abstract] [PDF] |
||||
![]() |
L. Sandrelli, O. Alfieri II, and W. van Oeveren The problem of priming solutions? The solution of priming problems Perfusion, July 1, 1992; 7(3): 217 - 221. [PDF] |
||||
![]() |
L. B. McGrath, L. Gonzalez-Lavin, and M. J. Neary Comparison of dextran 40 with albumin and Ringer's lactate as components of perfusion prime for cardiopulmonary bypass in patients undergoing myocardial revascularization Perfusion, January 1, 1989; 4(1): 41 - 49. [Abstract] [PDF] |
||||
![]() |
G. L. Hicks Jr., L. A. Jensen, L. H. Norsen, J. R. Quinn, S. S. Stewart, and J. A. DeWeese Platelet Inhibitors and Hydroxyethyl Starch: Safe and Cost-Effective Interventions in Coronary Artery Surgery Ann. Thorac. Surg., May 1, 1985; 39(5): 422 - 425. [Abstract] [PDF] |
||||
![]() |
C. R. Saunders, L. Carlisle, and R. L. Bick Hydroxyethyl Starch versus Albumin in Cardiopulmonary Bypass Prime Solutions Ann. Thorac. Surg., November 1, 1983; 36(5): 532 - 539. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |